Koyfin Home > Directory > Health Care > Aduro Biotech > EBITDA

Aduro Biotech EBITDA Chart (ADRO)

Aduro Biotech annual/quarterly EBITDA from 2013 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Aduro Biotech EBITDA for the quarter ending June 06, 2020 was $-14m a -31.01% increase of 4m year over year
  • Aduro Biotech EBITDA for the last 12 months ending June 06, 2020 was $-63m a -28.31% increase of 18m year over year
  • Aduro Biotech Annual EBITDA for 2019 was $-79m a -16.84% increase of 13m from 2018
  • Aduro Biotech Annual EBITDA for 2018 was $-92m a -10.88% increase of 10m from 2017
  • Aduro Biotech Annual EBITDA for 2017 was $-102m a 32.36% decrease of -33m from 2016
Other Income Statement Metrics:
  • Aduro Biotech Net Income for the quarter ending December 12, 2018 was $-26m a 18.34% decrease of -5m year over year
  • Aduro Biotech Total Revenue for the quarter ending December 12, 2018 was $3m a -140.28% decrease of -4m year over year
View Chart On Koyfin

Quarterly ADRO EBITDA Data

06/2020$-14m
03/2020$-9m
12/2019$-19m
09/2019$-18m
06/2019$-19m
03/2019$-21m
12/2018$-23m
09/2018$-24m
06/2018$-25m
03/2018$-21m

Annual ADRO EBITDA Data

2019$-79m
2018$-92m
2017$-102m
2016$-69m
2015$-12m
2014$-19m
2013$-14m
2012$-10m